Shopping Cart

Expired activity

Please go to the PowerPak homepage and select a course.

FACULTY

Justin W. Bouw, PharmD, BCACP, CDE
Assistant Professor
Clinical and Administrative Sciences
California Northstate University, College of Pharmacy
Elk Grove, Georgia

PROGRAM CHAIR

Terri Warholak, PhD, RPh, FAPhA

DIABETES PROGRAM PLANNER

Susan Sloane, RPh, CDE, CPT

CLINICAL REVIEWER FOR UPDATES

Joshua J. Neumiller, PharmD, CDE, FAADE, FASCP
Vice-Chair & Allen I. White Distinguished Associate Professor
Department of Pharmacotherapy
College of Pharmacy and Pharmaceutical Sciences
Washington State University

EDITORIAL REVIEWER FOR UPDATES

Laura K. Stinson, PharmD

FINANCIAL DISCLOSURE

Justin W. Bouw, PharmD, BCACP, CDE, has no relevant affiliations or financial relationships with a commercial interest to disclose.

Terri Warholak, PhD, RPh, FAPhA has no relevant affiliations or financial relationships with a commercial interest to disclose.

The following reviewers, Joshua J. Neumiller, PharmD, CDE, FAADE, FASCP and Laura K. Stinson, PharmD, have no relevant affiliations or financial relationships with a commercial interest to disclose.

Susanne Batesko, RN, BSN, Robin Carrino, and Susan Sloane, RPh, CDE, CPT, as well as the planners, managers, and other individuals, not previously disclosed, who are in a position to control the content of Postgraduate Healthcare Education (PHE) continuing education (CE) activities hereby state that they have no relevant conflicts of interest and no financial relationships or relationships to products or devices during the past 12 months to disclose in relation to this activity. We are committed to providing participants with a quality learning experience and to improve clinical outcomes without promoting the financial interests of a proprietary business.

ACCREDITATION STATEMENTS

PHARMACY
Postgraduate Healthcare Education, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
UAN: 0430-0000-19-037-H01-P
Credits: 2.0 hours (0.20 ceu)

Type of Activity: Knowledge
Media: Internet

Fee Information: Fee is included in the Pharmacist Diabetes MTM Certificate Program or $6.97 per course.

Estimated time to complete activity: 90 minutes

Published:

May 2, 2019

Expires:

May 2, 2022

TARGET AUDIENCE

This accredited activity has been designed for pharmacists.

This course was originally released May 1, 2016 under UAN #0430-0000-16-025-H01-P. Updates were provided throughout the accreditation period. May 2, 2019 additional updates provided to ensure medical accuracy/timely information and released under UAN#0430-0000-19-037-H01-P.

HOW TO EARN CREDIT

During the period May 2, 2019 through May 2, 2022 participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; and 3) complete the post-test and the evaluation form. To answer the questions, click on your selected choice for each answer then proceed to the next question. Once completed, click on Grade Exam at the bottom of the page. Your post-test will automatically be graded. If you successfully complete the post-test (score of 70% or higher), your statement of participation will be made available immediately. Click on the View Statement of Participation link and print the statement for your records. If you receive a score lower than 70%, you will receive a message notifying you that you did not pass the post-test. You will have 2 opportunities to pass the post-test. To receive Credit, you must provide your date of birth and NABP number. All Credit information will be uploaded into CPE monitor within 30 days.

GOAL

The goal of this CE module is to educate pharmacists on the basic concepts of blood glucose monitoring and interpretation of results to assist in the appropriate counseling and treatment of patients with diabetes mellitus.

EDUCATIONAL OBJECTIVES

Upon completion of this activity, participants should be better able to:

1. Recognize current glycemic goals and targets for people with diabetes;
2. Discuss glycosylated hemoglobin (A1C) and its role in diabetes management;
3. List the appropriate steps in using a blood glucose (BG) monitor;
4. Relate how to interpret self-monitoring of blood glucose (SMBG) results; and
5. Recognize how patients with diabetes may make therapy changes based on their SMBG readings with the help of their health care team.

REQUIRED COMPUTER HARDWARE/SOFTWARE

Please ensure the computer system you plan to use meets the following minimum requirements:

• Operating System: Windows 98 or higher & Macintosh 2.2 or higher
• Internet Browser (Mac & Windows): Internet Explorer 6.0 or higher, Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher & Opera 5 or higher
• Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible
• Monitor Screen Resolution: 320 x 480 or higher
• Media Viewing Requirements: Adobe Reader, Microsoft PowerPoint, Flash Player & HTML5

Disclosure of Unlabeled Use and Disclaimer

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Postgraduate Healthcare Education, LLC. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions, and possible contraindications on dangers in use, (review of any applicable manufacturer's product information) and comparison with recommendations of other authorities.

The author, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific knowledge at the time of acceptance for publication. However, because information regarding drugs (their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions, etc.) is subject to constant change, the reader is advised to check the manufacturer's package insert for information concerning recommended dosages and potential problems and cautions prior to dispensing or administering the drug. Special precautions should be taken when a drug is new, or highly toxic, or is unfamiliar to the dispenser or administrant. This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the U.S. Food and Drug Administration (FDA). Neither the publisher nor sponsor promotes the use of any agent outside of approved labeling. Statements made in this monograph have not been evaluated by the FDA. Nutritional products discussed are not intended for the diagnosis, treatment, cure, or prevention of any disease.